EPD Biotherapeutics
Developing innovative therapies with Engineered Protein Degraders.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD20—30m (Dealroom.co estimates Jun 2022.)
Company register number 3108134482
Seoul South Korea (HQ)